← k3vl4r
Log inGet started →

IONS (Ionis Pharmaceuticals) Price Forecast

AI-generated price forecast for Ionis Pharmaceuticals (IONS) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads IONS as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 26.99. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

26.99

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

IONS forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-58.11%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called IONS's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest IONS news

From the market-news feed the forecasts are read against.

  • TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG) · Yahoo · Nov 17
  • Ionis’ Tryngolza Wins European Commission Approval For Severe Hypertriglyceridemia, First RNA-Targeted Therapy In EU For Adults With Triglycerides ≥880 Mg/dL · Benzinga · Nov 16
  • Ionis Pharmaceuticals Sticks to $3 Billion TRYNGOLZA Sales Goal Despite Slow Start · Yahoo · Nov 16
  • The Strategy Exited Ionis Pharmaceuticals (IONS) Following Sequential Phase 3 Clinical Setbacks · Yahoo · Nov 13
  • Ionis presents new long-term data supporting durable efficacy and disease control with DAWNZERA® (donidalorsen) at ACAAI 2026 Annual Meeting · Yahoo · Nov 12

🔒

See the full IONS forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

IONS forecast — frequently asked

Will IONS go up?

K3vl4r's calibrated AI forecast currently reads IONS as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the IONS price prediction for 2026?

K3vl4r's model projects IONS toward $11.29 over the next ~4 weeks, a -58.1% move from $26.96. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

IFRXSNNEBSKTTAZYMEAUTLANABVYGRPIIIGMABNMRABRTXDNLIGNPX

Will IONS reach…?

Will IONS reach $50.00?Will IONS reach $100.00?Will IONS reach $200.00?

Or see the full IONS price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare IONS

IONS vs IFRXIONS vs SNNIONS vs EBSIONS vs KTTAIONS vs ZYMEIONS vs AUTL

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.